INFLUENZA VACCINE - SPLIT-PRODUCT VERSUS WHOLE-VIRUS TYPES - HOW DO THEY DIFFER

被引:42
作者
GROSS, PA
ENNIS, FA
机构
[1] HACKENSACK HOSP,HACKENSACK,NJ 07601
[2] US FDA,BETHESDA,MD 20014
关键词
D O I
10.1056/NEJM197703102961012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:567 / 568
页数:2
相关论文
共 12 条
[1]   INACTIVATED INFLUENZA VACCINE EFFICACY - DIMINISHED ANTIGENICITY OF SPLIT-PRODUCT VACCINES IN MICE [J].
BARRY, DW ;
STATON, E ;
MAYNER, RE .
INFECTION AND IMMUNITY, 1974, 10 (06) :1329-1336
[2]  
DAVENPORT FM, 1964, J LAB CLIN MED, V63, P5
[3]  
EVANS AS, 1973, SEROLOGICAL EPIDEMIO, P69
[4]  
GROSS PA, 1976, AM REV RESPIR DIS, V114, P305
[5]  
GROSS PA, 1976, 16TH INT C ANT AG CH
[6]   INFLUENZA VACCINES - SUMMARY OF INFLUENZA WORKSHOP .5. [J].
KILBOURNE, ED ;
DAVENPOR.FM ;
FOX, JP ;
CHANOCK, RM ;
JACKSON, GG ;
GREGG, MB ;
CHOPPIN, PW ;
PARKMAN, P .
JOURNAL OF INFECTIOUS DISEASES, 1974, 129 (06) :750-771
[7]  
Kilbourne Edwin D., 1975, INFLUENZA VIRUSES IN, P483
[8]  
MASUREL N, 1969, B WORLD HEALTH ORGAN, V41, P461
[9]  
PECK FB, 1968, J AMER MED ASSOC, V206, P2277
[10]  
RUBIN FL, 1972, J INFECT DIS, V125, P656